Immutep Limited
NASDAQ:IMMPBiotechnology
+$0.00 today
- Market cap
- $55.01M
- Beta
- 2.24
- P/E (TTM)
- -0.9
- EPS (TTM)
- -$0.06
Volume 3.10M
Average 13.46M
IMMP Total Current Liabilities
All obligations due within one year.
Immutep LimitedNASDAQ: IMMP
Total Current Liabilities · Q2 FY2026 · quarter ended Dec 2025
Total current liabilities rises 410.3% from a year ago
Total current liabilities stood at A$47.01M at the end of Q2 FY2026, up 410.3% from a year earlier. Over 3 fiscal years it compounded at +25.8% a year.
Context
- Total current liabilities amounted to 31.9% of total assets at the end of Q2 FY2026, up 26.9 pp from a year earlier.
- Total current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +410.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
AUD · from the balance sheet
- Latest · FY2025
- 12.76M AUD
- Year-over-year change
- +21.7%
- 4-year CAGR
- +24.3%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 12.76M | +21.7% |
| FY2024 | 2024-06-30 | 10.49M | +7.3% |
| FY2023 | 2023-06-30 | 9.77M | +52.3% |
| FY2022 | 2022-06-30 | 6.41M | +20.1% |
| FY2021 | 2021-06-30 | 5.34M | — |
Total Current Liabilities vs competitors
How IMMP compares with its peers on the latest reported figures
- Peers report in different currencies, so total current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +410.3% is the highest of 11, against a peer median of +0.3%.
- Total current liabilities amounts to 31.9% of total assets for IMMP, versus a peer median of 20.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $135.58M USD | +30.5% | +16.7% | 31.3% | |
| Dec 2025 | A$47.01M AUD | +410.3% | +25.8% | 31.9% | |
| Mar 2026 | $41.51M USD | +22.1% | +74.2% | 28.0% | |
| Mar 2026 | $39.78M USD | -45.6% | -8.4% | 26.6% | |
| Mar 2026 | €35.09M EUR | -3.6% | +15.6% | 35.4% | |
| Mar 2026 | $33.64M USD | +50.6% | +15.0% | 10.3% | |
| Mar 2026 | $28.33M USD | -5.6% | -15.4% | 7.2% | |
| Mar 2026 | $19.2M USD | +4.1% | +3.6% | 5.7% | |
| Mar 2026 | $11.83M USD | +66.0% | -25.1% | 35.7% | |
| Mar 2026 | $7.05M USD | -64.9% | +17.0% | 3.5% | |
| Mar 2026 | $6.18M USD | -17.6% | -43.9% | 15.2% | |
| Peer median (excluding IMMP) | — | +0.3% | +9.3% | 20.9% | |
Competitors are the stored peer set for IMMP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 60.13M | 80M | 123.42M | 161.79M | 67.41M |
| Short-term Investments | 0 | 0 | 0 | 20.09M | 62.28M |
| Net Receivables | 6.12M | 8.37M | 7.97M | 7.56M | 7.46K |
| Inventory | (5.66M) | 0 | 0 | 0 | 0 |
| Other Current Assets | 6.16M | 0 | 0 | 0 | 10.87M |
| Total Current Assets | 68.42M | 90.81M | 134.97M | 191.35M | 149.1M |
| Property, Plant & Equipment (Net) | 309.7K | 308.08K | 468.51K | 679.72K | 569.48K |
| Goodwill | 109.96K | 109.96K | 109.96K | 109.96K | 109.96K |
| Intangible Assets | 12.74M | 10.44M | 9.38M | 8.13M | 7.09M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 454.19K | 495.66K | 2.52M | 1.31M | 116.64K |
| Total Non-current Assets | 13.61M | 11.36M | 12.48M | 10.23M | 7.89M |
| Total Assets | 82.03M | 102.17M | 147.45M | 201.58M | 156.98M |
| Account Payables | 1.82M | 2.87M | 5.45M | 3.79M | 5.53M |
| Short-term Debt | 208.19K | 0 | 0 | 0 | 1.1M |
| Tax Payables | 0 | (32.21M) | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.75M | 3.02M | 354.84K | 428.71K | 446.95K |
| Total Current Liabilities | 5.34M | 6.41M | 9.77M | 10.49M | 12.76M |
| Long-term Debt | 2.53M | 1.45M | 835.45K | 960.76K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 811.88K | 117.25K | 164.43K | 211.02K | 274.31K |
| Total Non-current Liabilities | 3.42M | 1.68M | 1.21M | 1.57M | 589.23K |
| Total Liabilities | 8.76M | 8.09M | 10.98M | 12.06M | 13.35M |
| Common Stock | 313.42M | 367.41M | 446.27M | 542.11M | 535.07M |
| Retained Earnings | (274.64M) | (302.34M) | (339.93M) | (382.65M) | (444.08M) |
| Accumulated OCI | 34.49M | 29M | 30.13M | 30.06M | 52.65M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 73.27M | 94.08M | 136.47M | 189.52M | 143.64M |
| Total Debt | 2.82M | 1.73M | 1.23M | 1.59M | 1.63M |
| Net Debt | (57.31M) | (78.26M) | (122.19M) | (160.2M) | (65.78M) |
Immutep Limited
NASDAQ:IMMP
Intrinsic Alpha fair value
Locked
Current Price
$0.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.